Figure 7
Figure 7. Role of endothelial endoglin in leukocyte extravasation. A schematic diagram shows a hypothetical model for leukocyte transmigration through the vessel endothelium. (A) On inflammatory stimuli, different soluble factors are released, including the chemokine CXCL12, leading to activation and endoglin-dependent extravasation of leukocytes. (B) The leukocyte's transmigration process involves the binding of CXCL12 to its receptor CXCR4, which in turn activates the β1 integrins. Once activated, β1 integrin binds to the RGD motif of endoglin present on the endothelial cell (EC) surface, allowing the extravasation and migration of leukocytes to the inflammatory site. (C) Soluble endoglin competes for the binding between leukocyte β1 integrin and endothelial membrane anchored endoglin, thus interfering with leukocyte adhesion and transmigration. The dimeric nature of endoglin has been omitted for simplification.

Role of endothelial endoglin in leukocyte extravasation. A schematic diagram shows a hypothetical model for leukocyte transmigration through the vessel endothelium. (A) On inflammatory stimuli, different soluble factors are released, including the chemokine CXCL12, leading to activation and endoglin-dependent extravasation of leukocytes. (B) The leukocyte's transmigration process involves the binding of CXCL12 to its receptor CXCR4, which in turn activates the β1 integrins. Once activated, β1 integrin binds to the RGD motif of endoglin present on the endothelial cell (EC) surface, allowing the extravasation and migration of leukocytes to the inflammatory site. (C) Soluble endoglin competes for the binding between leukocyte β1 integrin and endothelial membrane anchored endoglin, thus interfering with leukocyte adhesion and transmigration. The dimeric nature of endoglin has been omitted for simplification.

Close Modal

or Create an Account

Close Modal
Close Modal